Heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-02-27. Numbers and descriptions here follow the published literature rather than marketing material.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
Anise tea, made from either the seeds or the leaves Asiatic penny-wort leaf, in South Asia and Southeast Asia Artichoke tea Commiphora gileadensis tea, in the Hijaz region of western Arabia. Bael fruit tea Barley tea, East Asian drink with roasted barley Bee balm Boldo, used in South America Burdock; the seeds, leaves, and roots have been used Butterfly pea flower tea (from Clitoria ternatea), also called "Blue tea" since it produces a blue infusion Caraway, tea made from the seeds Catnip, tea used as a relaxant, sedative, and to calm Chamomile, both Matricaria chamomilla and Chamaemelum nobile can be used Che dang, bitter tea made from Ilex causue leaves Chinese knotweed tea Chrysanthemum tea, made from dried flowers Cinnamon tea Clover tea, made from the blossoms Cerasse, bitter Jamaican herb Citrus peel, including bergamot, lemon and orange peel Dandelion coffee, which does not contain caffeine despite the name Dill tea Dried lime tea, made from dried limes common in western Asia Echinacea tea Elderberry European mistletoe (Viscum album), (steep in cold water for 2–6 hours) Essiac tea, blended herbal tea Fennel Gentian Ginger tea, made from the ginger root, can be made into herbal tea, known in the Philippines as salabat Ginkgo biloba Ginseng tea, a common tea in China and Korea, commonly used as a stimulant and as a caffeine substitute Goji berry tea Hawthorn Hibiscus tea (often blended with rose hip), a common tea in the Middle East or Asia Honeybush, similar to rooibos and grows in a nearby area of South Africa, but tastes slightly sweeter.
== Unsaturated fatty acids == β-Oxidation of unsaturated fatty acids poses a problem since the location of a cis-bond can prevent the formation of a trans-Δ2 bond which is essential for continuation of β-Oxidation as this conformation is ideal for enzyme catalysis. This is handled by additional two enzymes, Enoyl CoA isomerase and 2,4 Dienoyl CoA reductase.
==== Social issues ==== Larson has consistently voted both to legalize same-sex marriage and to expand options for legal abortion. He voted to repeal the military's "don't ask, don't tell" policy, and in favor of the Sexual Orientation Employment Nondiscrimination Act (ENDA). The Human Rights Campaign gave Larson a rating of 94%. Larson voted against ending federal funding to Planned Parenthood; consequently, both Planned Parenthood and NARAL Pro-Choice American gave him a rating of 100%.
=== Drug development === Tew's work on redox and pharmacogenetics focused on the discovery and development of drugs. Alongside colleagues, he introduced a novel zebrafish model with a glutathione S-transferase π1 (gstp1) knockout, revealing insights into redox homeostasis, reductive stress, and responses to drugs inducing endoplasmic reticulum stress and the unfolded protein response. His research has looked into the role of GTSP in cellular redox homeostasis and its over-expression in cancer drug resistance, particularly in the context of preclinical and clinical testing of the GSTP inhibitor TLK199 (Telintra) for treating myelodysplastic syndrome. He further revealed that the absence of microsomal glutathione transferase 1 (MGST1) impacts melanin biosynthesis and melanoma growth in mice and that, in numerous species, members of the GST family are involved in early hematopoiesis, and that the lack of GSTP in dendritic cells leads to increased proliferation, ROS levels and ERα levels, suggesting a role for GSTP in controlling ERα activity and dendritic cell function. Additionally, Tew and colleagues investigated how S-glutathionylation of the protein BiP, mediated by GSTP, contributes to acquired resistance to the multiple myeloma treatment bortezomib (Btz) by impacting BiP's foldase and ATPase activities.
Many RNAs are involved in modifying other RNAs. Introns are spliced out of pre-mRNA by spliceosomes, which contain several small nuclear RNAs (snRNA), or the introns can be ribozymes that are spliced by themselves. RNA can also be altered by having its nucleotides modified to nucleotides other than A, C, G and U. In eukaryotes, modifications of RNA nucleotides are in general directed by small nucleolar RNAs (snoRNA; 60–300 nt), found in the nucleolus and cajal bodies. snoRNAs associate with enzymes and guide them to a spot on an RNA by basepairing to that RNA. These enzymes then perform the nucleotide modification. rRNAs and tRNAs are extensively modified, but snRNAs and mRNAs can also be the target of base modification. RNA can also be methylated.
Sources: en.wikipedia.org
In 1981, Frank D. Hickingbotham (b. 1936) opened the first TCBY in Little Rock, Arkansas. TCBY began franchising the following year, and had expanded to over 100 locations by 1984. Prior to 1984, the company's name was "This Can't Be Yogurt," but a lawsuit from a competitor, I Can't Believe It's Yogurt!, forced TCBY to create a new name from its initials, eventually using "The Country's Best Yogurt". TCBY began co-branding with Taco Bell, McDonald's, Subway, and Burger King in 1995. In 1991 TCBY moved into the tallest building in Arkansas, the forty-story Simmons Tower located in downtown Little Rock, and the building was renamed The TCBY Tower until 2000 when TCBY vacated. Mrs. Fields acquired TCBY in early 2000 and became Mrs. Fields Famous Brands. The combined company relocated headquarters to Broomfield, Colorado in 2012. TCBY was also present in Honduras, Costa Rica and Nicaragua for several years, but closed all of its branches. In 2001, there were 1,777 TCBY locations across the United States. By 2011, after several waves of closings, there were 405.
== Environment == Dumping plastic waste: Thailand ranked sixth of 192 nations with ocean shorelines (1=worst, 192=best). Based on 2010 data, Thailand is estimated to have contributed 1.03 million tonnes of plastic waste to the ocean. The 10 biggest marine polluters (by millions of tonnes of plastic waste dumped in the ocean each year) are: China 8.8; Indonesia 3.2; The Philippines 1.9; Vietnam 1.8; Sri Lanka 1.6; Thailand 1.0; Egypt 1.0; Nigeria 0.9; Malaysia 0.9; and Bangladesh 0.8 Environmental Performance Index 2016: Thailand was ranked 91 of 180 nations (1=best, 180=worst) for its performance on environmental issues. Other ASEAN nations were ranked: Singapore, 14; Malaysia, 63; Philippines, 66; Brunei, 98; Indonesia, 107; Vietnam, 131; Cambodia, 146; Laos, 148; and Myanmmar, 153. Environmental Sustainability Index 2005: Ranked 73 of 146 countries. Fish species, threatened: Of 215 nations, Thailand ranked 12 (1=worst, 215=best) in fish species at risk (96 species) in 2014. ASEAN member-states ranked from number five (Indonesia) to 175 (Brunei). Mammal species, threatened: Of 214 countries studied, Thailand ranks ninth (1=worst, 214=best) in the world in the number of mammal species (55 species) under threat. ASEAN nations fared poorly in this study: Indonesia was number one on the world list with 184 species under threat. The remaining ASEAN nations were ranked: Malaysia, 7; Vietnam, 12; Myanmar, 14; Laos, 15; The Philippines, 19; Cambodia, 20; Brunei, 25; Singapore, 93, of 214 countries.
inorganic ions (typically monitored as electrical conductivity or resistivity or specific tests) organic compounds (typically monitored as TOC or by specific tests) bacteria (monitored by total viable counts or epifluorescence) endotoxins and nucleases (monitored by LAL or specific enzyme tests) particulates (typically controlled by filtration) gases (typically managed by degassing when required)
{\displaystyle u(n_{\mathrm {A} })^{2}\propto \left({\frac {\partial {n_{\mathrm {A} }}}{\partial R_{\mathrm {AB} }}}\right)^{2}u(R_{\mathrm {AB} })^{2}=n_{\mathrm {A} }^{2}{\frac {(R_{\mathrm {A} }-R_{\mathrm {B} })^{2}}{(R_{\mathrm {A} }-R_{\mathrm {AB} })^{2}(R_{\mathrm {AB} }-R_{\mathrm {B} })^{2}}}u(R_{\mathrm {AB} })^{2}}
Despite high total bismuth concentrations in the colon, antimicrobial activity in the colon is negligible because dominant forms of bismuth recovered (insoluble bismuth sulfide and methylated derivatives like TMBi) are microbiologically inactive; transformation into bismuth sulfide not only curtails further absorption but also minimizes potential toxicity and flora disruption.
Sources: en.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Identity is confirmed by matching the retention time in reversed-phase chromatography against a reference standard and by measuring the molecular mass with mass spectrometry. Tandem mass spectrometry or amino acid analysis can verify the sequence of the seven residues. Because the peptide contains no aromatic amino acids, detection at 280 nm is not useful.